New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types-Reference-Cited by-同舟云学术

New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types

Published:2024-03 Issue: Volume:201 Page:107092
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Gampala Silpa,Moon Hye-ran,Wireman Randall,Peil Jacqueline,Kiran Sonia,Mitchell Dana K.,Brewster Kylee,Mang Henry,Masters Andi,Bach Christine,Smith-Kinnamen Whitney,Doud Emma H.,Rai Ratan,Mosley Amber L.,Quinney Sara K.,Clapp D. Wade,Hamdouchi Chafiq,Wikel James,Zhang Chi,Han Bumsoo,Georgiadis Millie M.,Kelley Mark R.,Fishel Melissa L.

Funder

National Heart Lung and Blood Institute

National Eye Institute

National Cancer Institute

Publisher

Elsevier BV

Reference77 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Annual report to the nation on the status of cancer, part 1: National cancer statistics;Cronin;Cancer,2022

3. Annual report to the nation on the status of cancer, part I: National cancer statistics;Henley;Cancer,2020

4. Global cancer statistics 2022: the trends projection analysis;Chhikara;Chem. Biol. Lett.,2022

5. Small molecule inhibitors in pancreatic cancer;Sun;RSC Med. Chem.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in a novel model of autophagy and immune network regulation in radioresistance of cancer stem cells;Biomedicine & Pharmacotherapy;2024-10

2. Interface-driven structural evolution on diltiazem as novel uPAR inhibitors: from in silico design to in vitro evaluation;Molecular Diversity;2024-06-27

3. Fast-relaxing hydrogels with reversibly tunable mechanics for dynamic cancer cell culture;Biomaterials Advances;2024-05

4. AP endonuclease 1: Biological updates and advances in activity analysis;Methods in Enzymology;2024